Search research articles
Contact Us
Filters
Showing results (111-120 of 138) with videos related to
Page
of 14
Sort By:
Biopharmaceutics & Drug Disposition
|
May 1, 1988
In vitro protein binding interaction studies involving cefixime
M Bialer, W H Wu, R D Faulkner, et al.
Epilepsia
|
May 22, 1998
Criteria to assess in vivo performance and bioequivalence of generic controlled-release formulations of carbamazepine
M Bialer, A Yacobi, D Moros, et al.
Epilepsy Research
|
January 4, 2001
Progress report on new antiepileptic drugs: a summary of the Fifth Eilat Conference (EILAT V)
M Bialer, S I Johannessen, H J Kupferberg, et al.
Epilepsy Research
|
November 1, 1996
Progress report on new antiepileptic drugs: a summary of the Third Eilat Conference
M Bialer, S I Johannessen, H J Kupferberg, et al.
Biopharmaceutics & Drug Disposition
|
July 1, 1991
Stability of diltiazem in different biological fluids
A M McLean, E A Cefali, J S Roden, et al.
Pharmaceutical Research
|
June 1, 1991
Pharmacokinetics and anticonvulsant activity of three monoesteric prodrugs of valproic acid
K Badir, A Haj-Yehia, T B Vree, et al.
Clinical Pharmacology and Therapeutics
|
April 1, 1997
Stereoselective pharmacokinetic analysis of valnoctamide in healthy subjects and in patients with epilepsy
S Barel, B Yagen, V Schurig, et al.
Epilepsy Research
|
April 8, 1999
Progress report on new antiepileptic drugs: a summary of the fourth Eilat conference (EILAT IV)
M Bialer, S I Johannessen, H J Kupferberg, et al.
Epilepsy Research
|
September 28, 2002
Progress report on new antiepileptic drugs: a summary of the Sixth Eilat Conference (EILAT VI)
M Bialer, S I Johannessen, H J Kupferberg, et al.
Biopharmaceutics & Drug Disposition
|
October 1, 1996
Pharmacokinetic and pharmacodynamic analysis of (E)-2-ene valproyl derivatives of glycine and valproyl derivatives of nipecotic acid
M Bialer, B Kadry, A Abdul-Hai, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 138) with videos related to
Sort By:
Page
of 14
Biopharmaceutics & Drug Disposition
|
May 1, 1988
In vitro protein binding interaction studies involving cefixime
M Bialer, W H Wu, R D Faulkner, et al.
Epilepsia
|
May 22, 1998
Criteria to assess in vivo performance and bioequivalence of generic controlled-release formulations of carbamazepine
M Bialer, A Yacobi, D Moros, et al.
Epilepsy Research
|
January 4, 2001
Progress report on new antiepileptic drugs: a summary of the Fifth Eilat Conference (EILAT V)
M Bialer, S I Johannessen, H J Kupferberg, et al.
Epilepsy Research
|
November 1, 1996
Progress report on new antiepileptic drugs: a summary of the Third Eilat Conference
M Bialer, S I Johannessen, H J Kupferberg, et al.
Biopharmaceutics & Drug Disposition
|
July 1, 1991
Stability of diltiazem in different biological fluids
A M McLean, E A Cefali, J S Roden, et al.
Pharmaceutical Research
|
June 1, 1991
Pharmacokinetics and anticonvulsant activity of three monoesteric prodrugs of valproic acid
K Badir, A Haj-Yehia, T B Vree, et al.
Clinical Pharmacology and Therapeutics
|
April 1, 1997
Stereoselective pharmacokinetic analysis of valnoctamide in healthy subjects and in patients with epilepsy
S Barel, B Yagen, V Schurig, et al.
Epilepsy Research
|
April 8, 1999
Progress report on new antiepileptic drugs: a summary of the fourth Eilat conference (EILAT IV)
M Bialer, S I Johannessen, H J Kupferberg, et al.
Epilepsy Research
|
September 28, 2002
Progress report on new antiepileptic drugs: a summary of the Sixth Eilat Conference (EILAT VI)
M Bialer, S I Johannessen, H J Kupferberg, et al.
Biopharmaceutics & Drug Disposition
|
October 1, 1996
Pharmacokinetic and pharmacodynamic analysis of (E)-2-ene valproyl derivatives of glycine and valproyl derivatives of nipecotic acid
M Bialer, B Kadry, A Abdul-Hai, et al.
Page
of 14